Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease
Reexamination Certificate
2006-07-04
2006-07-04
Schwadron, Ronald B. (Department: 1644)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Transferase other than ribonuclease
C435S193000, C530S350000
Reexamination Certificate
active
07070972
ABSTRACT:
An isolated polynucleotide encodes JAK-3 protein. JAK-3 protein is a protein tyrosine kinase having a molecular weight of approximately 125 kDa which has tandem non-identical catalytic domains, lacks SH2 or SH3 domains, and is expressed in NK cells and stimulated or transformed T cells, but not in resting T cells. The protein itself and antibodies to this protein are also presented. Further, methods of identifying therapeutic agents for modulating the immune system make use of the foregoing.
REFERENCES:
patent: 5124251 (1992-06-01), Lanier et al.
patent: 5262522 (1993-11-01), Gearing
patent: 5283354 (1994-02-01), Lemischka
patent: 5705625 (1998-01-01), Civin et al.
patent: 5916792 (1999-06-01), Civin et al.
patent: 6136595 (2000-10-01), Ihle et al.
patent: 9400469 (1994-01-01), None
Lai et al., Blood, vol. 84 (10 Suppl 1), 294A, 1994.
Safford et al., Blood, vol. 84 (10 Suppl 1), 122A, 1994.
Zeng et al., FEBS Letters, 353:289-293, 1994.
Asao et al., FEBS Letters, 351:201-206, 1994.
Takahashi et al., FEBS Letters, 342:124-128, 1994.
Rane et al., Oncogene, 9:2415-2423, 1994.
Miyazaki et al., Science, 266:1045-1047, 1994.
Beadling et al., EMBO J., 13:5605-5615, 1994.
Kirkew et al., J. Biol. Chem., 268:22765-22770, 1993.
Hunter, Tony; Nature, vol. 366, Nov. 11, 1993; pp. 114-116; “Cytokine Connections”.
McVicar, et al.; Oncogene, Jul. 1994 9(7), pp. 2037-2044; “Molecular Cloing of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes”.
Kawamura, et al.; Proc.Natl.Acad.Sci.USA, vol. 91, pp. 6374-6378, Jul. 1994; “Molecular cloing of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes”.
Russell, et al.; “Interaction of Interleukin-2 Receptor β chain and common Chain with JAK1 and JAK3, respectively:defective Jak3 Association in X-linked Severe Combined Immunodeficiency”. AIDS Res. and Human Retrovir. vol. 10 (Suppl 3), 1994, 573.
Gnarra, et al., Proc.Natl.Acad.Sci.USA; vol. 87, pp. 3440-3444, May 1990, Immunology; “Human interleukin 2 receptor β-chain gene: Chromosomal localization and identification of 5′ regulatory sequences”.
Russell, et al.; Science, vol. 262, Dec. 17, 1993; pp. 1880-1883; “Interleukin-2 receptor γ Chain: A functional Compnent of the Interleukin-4 receptor”.
Noguchi, et al. ; The Journal of Biological Chemistry; vol. 268, No. 18, Jun. 25, 1993, pp. 13601-13608; “Characterization of the Human Interleukin-2 Receptor γ Chain Gene”.
Russell, et al.; Science, vol. 266, Nov. 11, 1994; pp. 1042-1045; “Interaction of IL-2Rβ and γ chains with Jak1 and Jak3: Implications for XSCID and XCID”.
Takebe, et al.; Molecular and Cellular Biology, Jan. 1988, pp. 466-472; “Sr Promoter: an Efficient and Versatile Mammalian cDNA Expression System Composed of the Simian Virus 40 Early Promoter and the R-U5 Segment of Human T-Cell Leukemia Virus Type 1 Long Terminal Repeat”.
Nakamura et al.; Nature, vol. 369; May 26, 1994, pp. 330-333; “Heterodimerization of the IL-2 receptor β and γ chain ccytoplasmic domains is required for signaling”.
Cance, et al.; INt.J. Cancer: 54, 571-577 (1993); “Novel Protein Kinases expressed in human breast cancer”.
Johnston, et al.; Nature, vol. 370, Jul. 14, 1994; pp. 151-153; “Phosphorylation and activation of the Jak-3 Janus Kinase in response to Interleukin-2”.
Withuhn, et al.; Nature, vol. 370, Jul. 14, 1994; pp. 153-157; “Involvement of the JAk-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells”.
Sanchez, et al.; Proc.Natl.Acad.Sci.USA, vol. 91, pp. 1819-1823, Mar. 1994, Neurobiology; “Multiple tyrosine protein kinases in rat hippocampal neurons: Isolation of Ptk-3, a receptor expressed in proliferative zones of the developing brain”.
Siliciano, et al.; Proc.Natl.Acad.Sci.USA, vol. 89, pp. 11194-11198; Dec. 1992; Biochemistry; “itk, a T-cell-specific thyrosine kinase gene inducible by interleukin 2”.
Vitte-Mony, et al.; 1994 Elsevier Science Ltd, Mol. Immunol. Jun. 1994; pp. 623-632; “Signal Transduction of interleukin 2 in Human Natural Killer Cells: Involvement of the p56lckTyrosine Kinase”.
Sharon, et al.; Proc.Natl.Acad.Sci.USA; vol. 87, pp. 4869-4873, Jun. 1990, Immunology; “A 100-kilodalton protein is associated with the murine interleukin 2 receptor: Biochemical evidence that p100 is distinct from the α and β chains”.
Bennett, et al.; The Journal of Biological Chemistry, vol. 269, No. 2, Issue of Jan. 14, pp. 1068-1074, 1994; “Identification and Characterization of a Novel Tyrosine Kinase from Megakaryocytes”.
Stahl, et al.; Cell, vol. 74, pp. 587-590, August 27, 1993; “The Alphas, Betas, and kinases of Cytokine Receptor Complexes”.
Johnston James A.
Kawamura Masaru
Leonard Warren J.
McVicar Daniel W.
O'Shea John J.
Knobbe Martens Olson & Bear LLP
Schwadron Ronald B.
The United States of America as represented by the Department of
LandOfFree
Janus family kinases and identification of immune modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Janus family kinases and identification of immune modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Janus family kinases and identification of immune modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3547745